Revvity Inc vs Banco Santander SA — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Banco Santander SA trades at $13.74 (market cap $191.46B). The key difference: Banco Santander SA is far larger — about 16.1× Revvity Inc's market cap, and Banco Santander SA pays the higher dividend (2.09%). Which is the better fit depends on your goals.
| RVTY | SAN | |
|---|---|---|
Market Cap | $11.87B | $191.46B |
Sector | Technology | Financials |
52-Week High | $117.75 | $14.37 |
52-Week Low | $82.26 | $8.40 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | 2.09% |
Trailing returns across standard periods
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →